Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly vs Daily Folic Acid Supplementation
NCT00394862Phase 3Completed
- Sponsor
- Emory University
- Start
- Jan 2006
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of folic acid in neural tube defects (NTDs) (4 arms), sponsored by Emory University. Primary endpoints: Serum folate level at 3 months and Red blood cell folate at 3 months. Started Jan 2006; status: completed.
02
Drugs
folic acid
03
Conditions
neural tube defects (NTDs)
Beyond the preview
Go deeper on NCT00394862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394862.